Northeast Florida Clinical Trials and Translational Science Consortium

The Northeast Florida Clinical Trials and Translational Science (NEF-CTaTS) Consortium was established in 2022 to address healthcare disparities in Northeast Florida by increasing the number of underrepresented minorities in biomedical clinical trials. Under the visionary leadership of a dedicated team of physicians and academic scientists, we are creating partnerships to enhance racial and ethnic diversity of clinical trials. To date, we have secured a partnership with Mayo Clinic Florida.

The NEF-CTaTS Consortium is administratively supported by the Northeast Florida Medical Society Foundation (NEFMSF), the 503B arm of Northeast Florida Medical Society (NEFMS). NEFMS is an affiliate of the Florida State Medical Association and the National Medical Association, the oldest and largest national organization representing African American physicians and their patients. We invite you to learn more about our goals to be involved and improve our health.

We invite you to learn more about our goals to be involved and improve our health.

Our Vision

Our vision is to develop a community engaged “Clinical Trials and Translational Science Consortium” based on the priorities of underrepresented communities in Northeast Florida. The consortium will foster unique collaborations supported by research infrastructure and other resources to eliminate disparities, leveraging the resources of other consortium institutions and organizations as well as the expertise of all consortium members.

Our Goals

Our goal is to address health disparities experienced by minority and underserved communities in Northeast Florida. Specifically, the NEF-CTaTS Consortium will improve health outcomes by eliminating barriers to cancer trials and relevant clinical research opportunities for people of color.